A detailed history of Forefront Analytics, LLC transactions in Incyte Corp stock. As of the latest transaction made, Forefront Analytics, LLC holds 5,747 shares of INCY stock, worth $423,956. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,747
Previous 6,158 6.67%
Holding current value
$423,956
Previous $373,000 1.61%
% of portfolio
0.18%
Previous 0.18%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $23,562 - $28,198
-411 Reduced 6.67%
5,747 $379,000
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $32,089 - $39,971
627 Added 11.34%
6,158 $373,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $48,802 - $57,467
863 Added 18.49%
5,531 $315,000
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $58,940 - $72,534
1,130 Added 31.94%
4,668 $293,000
Q3 2023

Nov 07, 2023

BUY
$57.77 - $65.93 $288 - $329
5 Added 0.14%
3,538 $204,000
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $487 - $604
8 Added 0.23%
3,533 $219,000
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $15,029 - $18,406
214 Added 6.46%
3,525 $254,000
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $222,432 - $278,488
3,311 New
3,311 $265,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.